Many PKC isozymes, including α, δ, and ε, undergo proteasomal ubiquitination in response to tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA). The gene discussed is PRRT2; the disease is neoplasm.